Cipla reported its consolidated financial results for Q2 FY26, showing a revenue increase but a decline in net profit. Revenue from operations increased to ₹7,589.44 crores, while net profit after tax decreased to ₹1,353.37 crores. The company’s expenses also saw an increase, impacting overall profitability. The board approved these results at a meeting held on October 30, 2025.
Financial Performance
Cipla announced its unaudited consolidated financial results for Q2 FY26. Key highlights include:
- Revenue from Operations: Increased to ₹7,589.44 crores compared to previous periods.
- Other Income: ₹268.95 crores.
- Total Income: ₹7,858.39 crores.
- Net Profit After Tax: ₹1,353.37 crores.
Expense Analysis
The company’s expenses also saw significant movements:
- Cost of Materials Consumed: ₹1,528.16 crores.
- Employee Benefits Expense: ₹1,314.80 crores.
- Other Expenses: ₹1,882.25 crores.
Segment Performance
A breakdown of the segment revenue is as follows:
- Pharmaceuticals: ₹7,291.43 crores.
- New Ventures: ₹350.68 crores.
Equity and Liabilities
The consolidated statement of assets and liabilities shows:
- Equity Share Capital: ₹161.55 crores.
- Other Equity: ₹32,757.44 crores.
Litigation Matters
Cipla has reviewed notices related to alleged overcharging, with the total amount under litigation aggregating to approximately ₹2,011 crores. The company expects a favorable outcome and has made provisions accordingly.
Increase in Equity Share Capital
The paid-up equity share capital increased to ₹161.55 crores following the allotment of shares under the ESOS 2013-A and Cipla ESAR Scheme 2021 during the quarter ended September 30, 2025.
Auditor’s Review
The results have been reviewed by the Audit Committee and approved by the Board of Directors on October 30, 2025. The statutory auditors have provided an unmodified review conclusion.
Source: BSE